NF1 and sarcoma: Although rare in tumors such as gastric cancer, sarcoma, and renal cell carcinoma, recent finding that NF1 mutations are enriched (11%) in oncogene-negative subset of lung adenocarcinomas, and our finding suggests novel therapeutic opportunities for the subset of patients with NF1 mutations.